Fresenius Medical Care AG
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
157 / 302
Position in country
523 / 963
Return on Assets, %
2
0.1
Net income margin, %
5.1
0.6
EBITDA margin, %
19.4
8.9
Debt to Equity, %
88.4
34.4
Intangible assets and goodwill, %
47.1
15.8
Revenue CAGR 3Y, %
2.8
11.7
Total Equity change 1Y, %
0.3
0
Revenue Y, % chg
3.5
1.8
P/E
20.3
25.7
P/BV
0.7
1.2
P/S
0.5
1.2
EV/S
1.1
1.5
EV/EBITDA
6.4
6.9
Average Analyst recommendation
Sell
Sell
Average upside forecasts, %
4.4
45.6
Forward P/E
8.4
17.8
Dividend Yield, %
3.2
2.6
Forward Dividend Yield, %
5
0.4
Expected dividend per share
0.9
0
Payout Ratio, %
69.9
18.7
Dividend Ex Date
2023-05-17
Competitors
Ranks
-
CorVel Corp
00%
-
Cigna Group
00%
-
CVS Health Corp
00%
-
Fresenius SE & Co KGaA
00%
-
DaVita Inc
00%
-
RadNet Inc
00%
-
Fresenius Medical Care AG
00%
-
Quest Diagnostics Inc
00%
-
Laboratory Corporation of America Holdings
00%
-
Synlab AG
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
Germany
Sector
Health Care
Industry group
Health Care Equipment & Services
Industry
Health Care Providers & Services
Sub-sector
Health Care
Capitalization (millions of $)
11151.4
Ticker
FMS.N
ISIN
US3580291066
IPO date
1996-10-02
Availability on Russian exchanges
Yes
Reporting for
2024-03-22
Date fact. publication of reports
2023-12-31
Company Description
Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: